[ Price : $8.95]
FDA medical reviewers question the demonstration of efficacy in an Otsuka NDA for a combination of Rexulti and Zoloft to treat PTS...[ Price : $8.95]
FDA lifts a partial clinical hold against Kezar Life Sciences and its completed PORTOLA Phase 2a clinical trial evaluating zetomip...[ Price : $8.95]
FDA clears a Caranx Medical 510(k) for its TaviPilot Soft, which the company describes as AI software for real-time intra-operativ...[ Price : $8.95]
Sandoz expands a 6/25 recall of cefazolin for injection to include one additional lot after the company received a customer compla...[ Price : $8.95]
HHS notifies over 3,000 FDA employees that their employment has been officially terminated effective 7/14.[ Price : $8.95]
FDA warns South Koreas Daewoo Pharmaceutical Co. about CGMP violations in its production of finished drugs.[ Price : $8.95]
A Benefits Pensions Monitor report says FDA drug inspection backlogs can hurt Canada since FDA has been performing 70% of Canadas ...[ Price : $8.95]
FDA reviewers plan to ask an advisory committee this week about its concerns with ocular toxicity seen in trial data submitted by ...